A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer

NCT05567679 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI voluntarily closed the study.

Conditions

Prostate Cancer

Interventions

DRUG: Tazverik

Sponsor

Edwin Posadas, MD

Collaborators

[object Object]